NVIDIA Genomics Submits IPO Prospectus Highlighting GPU-Accelerated Solutions for Pandemic Response and Life Sciences
Dec 01, 2020 16:59
CST Updated
16:59
NVIDIA
Artificial Intelligence Computing Service Provider
Using GPUs to Analyze Short-Read Sequencing Data of the Novel Coronavirus (COVID-19)
Monitoring COVID-19 Using Oxford Nanopore Sequencers
Containerized Life Science Applications Enhance Supercomputer Portability
Clara SDK Enables Training Functions for COVID-19 Related R&D
GPU-Accelerated Biomolecular Simulation and AI-Enabled Chemistry
To learn more about NVIDIA’s healthcare and life sciences solutions, please click here.Special ProPage.